By Jennifer Rigby and Vincent Mumo Nzilani LONDON/NAIROBI, July 21 (Reuters) - Around 77,000 fewer children worldwide received HIV treatment supported by the U.S. in the year to October 2025 than in ...
Studies revealing the real-world impact of disruptions to the US President’s Emergency Plan for AIDS Relief (PEPFAR) and important advances in long-acting HIV prevention and treatment were announced ...
Gilead Sciences & Merck announce investigational once-weekly oral HIV treatment regimen of islatravir and lenacapavir maintained virological suppression in adults with HIV who swi ...
A new report says the Trump administration’s disruptions to a global AIDS relief program have forced organizations to close ...
The Trump administration’s disruptions to a global AIDS relief program have forced organizations to close clinics, lay off ...
Gilead Sciences plans to present new HIV research data at AIDS 2026. The presentations will include long term efficacy and ...
The Trump administration’s cuts to the largest global H.I.V. program last year resulted in sharp drops in both prevention ...
UNAIDS chief calls for ‘radical change’ as aid cuts gut HIV clinics and treatment worldwide.
Gilead Sciences and Merck said on Tuesday their experimental once-weekly HIV pill kept the virus suppressed in two late-stage trials, ​supporting regulatory filings for what could become the first ...
A total of 1,906 One thousand nine hundred and six new positive HIV/AIDS cases were registered in the first half of the current year across various health units in the province of Lunda-Sul.According ...